Global Information
회사소개 | 문의 | 위시리스트

세계의 인간 인슐린 제제 및 투약 기기 시장 : 성장 동향과 경쟁 분석

Global Human Insulin Drugs And Delivery Devices Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

리서치사 QYResearch
발행일 2019년 07월 상품 코드 897482
페이지 정보 영문
가격
US $ 5,600 ₩ 6,722,000 PDF by E-mail (Single User License)
US $ 8,400 ₩ 10,084,000 PDF by E-mail (Multi User License)
US $ 11,200 ₩ 13,445,000 PDF by E-mail (Enterprise Wide License)


세계의 인간 인슐린 제제 및 투약 기기 시장 : 성장 동향과 경쟁 분석 Global Human Insulin Drugs And Delivery Devices Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
발행일 : 2019년 07월 페이지 정보 : 영문

세계의 인간 인슐린 제제 및 투약 기기(Human Insulin Drugs And Delivery Devices) 시장을 조사했으며, 시장 및 제품 개요, 제조량·제조액·가격 등의 추정과 예측, 종류·용도·지역·기업별 상세 분석, 시장에 대한 각종 영향요인 분석, 주요 기업 개요 등을 정리했습니다.

제1장 보고서 개요

  • 조사 범위
  • 조사 대상 기업
  • 시장 분석 : 종류별
    • 성장률
    • 인슐린 펌프
    • 인슐린 펜
    • 인슐린 주사기
    • 기초/지속형 인슐린
    • 추가/속효형 인슐린
  • 시장 분석 : 용도별
    • 시장 점유율
    • 병원용
    • 가정용
  • 조사 목적
  • 조사 대상년도

제2장 세계의 성장 동향

  • 제조능력·제조량·제조액·가격 추정과 예측
  • 주요 제조 지역 및 국가의 연평균 성장률(CAGR)
  • 산업 동향

제3장 주요 기업과 시장 점유율

  • 제조능력·제조량 점유율
  • 매출·매출 점유율
  • 가격
  • 공장의 분포와 영업 지역
  • 시장 진출 시기
  • 제공 제품
  • M&A, 확장 계획

제4장 시장 규모 추정 : 종류별

제5장 시장 규모 추정 : 용도별

제6장 제조 동향 : 지역별

  • 제조량·제조액 추정 : 지역별
  • 미국
    • 제조량 성장률
    • 제조액 성장률
    • 주요 기업
    • 수출입수
  • 유럽
    • 제조량
    • 매출
    • 주요 기업
    • 수출입수
  • 중국
    • 제조량
    • 매출
    • 주요 기업
    • 수출입수
  • 일본
    • 제조량
    • 매출
    • 주요 기업
    • 수출입수
  • 기타 지역
    • 한국
    • 인도
    • 동남아시아

제7장 소비 동향 : 지역별

  • 소비량 추정 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 중동 및 아프리카

제8장 기업 개요

  • Novo Nordisk
  • Sanofi Aventis
  • Eli Lilly
  • Biocon
  • Julphar
  • Exir
  • Medtronic
  • Insulet
  • Ypsomed
  • Becton Dickinson

제9장 제조 예측

  • 제조능력·제조량·제조액 예측
  • 제조량·제조액 예측 : 지역별
  • 주요 제조 지역 및 국가 예측
    • 미국
    • 유럽
    • 중국
    • 일본
    • 기타 지역
  • 제조량·제조액 예측 : 종류별

제10장 소비 예측

  • 소비량 예측 : 용도별
  • 소비량 예측 : 지역별

제11장 밸류체인 및 판매 경로 분석

제12장 시장 기회, 과제, 위협, 영향요인 분석

제13장 주요 조사 결과

제14장 부록

KSM 19.08.08

List of Tables and Figures

  • Figure Human Insulin Drugs And Delivery Devices Product Picture
  • Table Human Insulin Drugs And Delivery Devices Key Market Segments
  • Table Major Manufacturers Human Insulin Drugs And Delivery Devices Covered in This Report
  • Table Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Sales Market Shar by Type 2014-2025
  • Figure Insulin Pumps Figures
  • Table Major Manufacturers of Insulin Pumps
  • Figure Insulin Pens Figures
  • Table Major Manufacturers of Insulin Pens
  • Figure Insulin Syringes Figures
  • Table Major Manufacturers of Insulin Syringes
  • Figure Basal or Long Acting Insulins Figures
  • Table Major Manufacturers of Basal or Long Acting Insulins
  • Figure Bolus or Fast-Acting Insulins Figures
  • Table Major Manufacturers of Bolus or Fast-Acting Insulins
  • Table Global Human Insulin Drugs And Delivery Devices Market Share by Application 2019-2025 (K Units)
  • Figure Hospital Use Case
  • Figure Household Use Case
  • Figure Human Insulin Drugs And Delivery Devices Report Years Considered
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2025 (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Production 2014-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Capacity 2014-2025 (K Units)
  • Table Key Manufacturers Human Insulin Drugs And Delivery Devices Capacity (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Price 2014-2025 (USD/Unit)
  • Table Global Human Insulin Drugs And Delivery Devices Market Size of Key Regions (Million USD) & (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Growth Rate of Key Regions 2019-2025 (Million USD)
  • Table Global Human Insulin Drugs And Delivery Devices Market Share for of Regions 2019-2025 (K Units)
  • Table Market Top Trends
  • Table Global Human Insulin Drugs And Delivery Devices Capacity by Manufacturers (2014-2019) (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Capacity Market Share by Manufacturers (2014-2019)
  • Table Global Human Insulin Drugs And Delivery Devices Production by Manufacturers (2014-2019) (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Production Share by Manufacturers (2014-2019)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Share by Manufacturers in 2018
  • Table Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2014-2019) (Million USD)
  • Table Human Insulin Drugs And Delivery Devices Revenue Share by Manufacturers (2014-2019)
  • Figure Human Insulin Drugs And Delivery Devices Value Share by Manufacturers in 2018
  • Table Global Human Insulin Drugs And Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Human Insulin Drugs And Delivery Devices Price by Manufacturers 2014-2019 (USD/Unit)
  • Table Key Manufacturers Human Insulin Drugs And Delivery Devices Plants/Factories Distribution
  • Table Key Manufacturers Human Insulin Drugs And Delivery Devices Area Served
  • Table Date of Key Manufacturers Enter into Human Insulin Drugs And Delivery Devices Market
  • Table Key Manufacturers Human Insulin Drugs And Delivery Devices Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Insulin Pumps Production and Production Value (2014-2019) (K Units) & (Million US$)
  • Table Global Insulin Pens Production and Production Value (2014-2019) (K Units) & (Million US$)
  • Table Global Insulin Syringes Production and Production Value (2014-2019) (K Units) & (Million US$)
  • Table Global Basal or Long Acting Insulins Production and Production Value (2014-2019) (K Units) & (Million US$)
  • Table Global Bolus or Fast-Acting Insulins Production and Production Value (2014-2019) (K Units) & (Million US$)
  • Table Global Human Insulin Drugs And Delivery Devices Production by Type (2014-2019) (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Production Share by Type (2014-2019)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share by Type (2014-2019)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share by Type in 2018
  • Table Global Human Insulin Drugs And Delivery Devices Production Value by Type (2014-2019) (Million US$)
  • Table Global Human Insulin Drugs And Delivery Devices Production Value Share by Type (2014-2019)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Type (2014-2019)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Type in 2018
  • Table Human Insulin Drugs And Delivery Devices Ex-factory Price by Type 2014-2019 (USD/Unit)
  • Table Global Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Consumption Share by Application (2014-2019)
  • Figure Global Consumption Human Insulin Drugs And Delivery Devices Market Share by Application (2014-2019)
  • Table Global Human Insulin Drugs And Delivery Devices Production by Regions 2014-2019 (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Production Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share by Regions in 2018
  • Table Global Human Insulin Drugs And Delivery Devices Production Value by Regions 2014-2019 (Million USD)
  • Table Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Regions in 2018
  • Table United States Human Insulin Drugs And Delivery Devices Production and Value 2014-2019 (K Units) & (Million USD)
  • Figure United States Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019 (K Units)
  • Figure United States Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019 (Million USD)
  • Table United States Human Insulin Drugs And Delivery Devices Import & Export (K Units)
  • Table Europe Human Insulin Drugs And Delivery Devices Production and Value 2014-2019 (K Units) & (Million USD)
  • Figure Europe Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019 (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019 (Million USD)
  • Table Europe Human Insulin Drugs And Delivery Devices Import & Export (K Units)
  • Table China Human Insulin Drugs And Delivery Devices Production and Value 2014-2019 (K Units) & (Million USD)
  • Figure China Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019 (K Units)
  • Figure China Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019 (Million USD)
  • Table China Human Insulin Drugs And Delivery Devices Import & Export (K Units)
  • Table Japan Human Insulin Drugs And Delivery Devices Production and Value 2014-2019 (K Units) & (Million USD)
  • Figure Japan Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019 (K Units)
  • Figure Japan Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019 (Million USD)
  • Table Japan Human Insulin Drugs And Delivery Devices Import & Export (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Consumption by Regions 2014-2019 (K Units)
  • Table Global Human Insulin Drugs And Delivery Devices Consumption Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Market Share by Regions 2014-2019
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Market Share by Regions in 2018
  • Figure North America Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table North America Human Insulin Drugs And Delivery Devices Consumption by Type (2014-2019) (K Units)
  • Figure North America Human Insulin Drugs And Delivery Devices Consumption Market Share by Type in 2018
  • Table North America Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Figure North America Human Insulin Drugs And Delivery Devices Consumption Market Share by Application in 2018
  • Table North America Human Insulin Drugs And Delivery Devices Consumption by Countries (2014-2019) (K Units)
  • Figure North America Human Insulin Drugs And Delivery Devices Consumption Market Share by Countries in 2018
  • Figure United States Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Canada Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Mexico Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table Europe Human Insulin Drugs And Delivery Devices Consumption by Type (2014-2019) (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Consumption Market Share by Type in 2018
  • Table Europe Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Consumption Market Share by Application in 2018
  • Table Europe Human Insulin Drugs And Delivery Devices Consumption by Countries (2014-2019) (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Consumption Market Share by Countries in 2018
  • Figure Germany Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure France Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure UK Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Italy Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Russia Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Type (2014-2019) (K Units)
  • Figure Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Market Share by Type in 2018
  • Table Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Figure Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Market Share by Application in 2018
  • Table Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Regions (2014-2019) (K Units)
  • Table Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Market Share by Countries (2014-2019)
  • Figure China Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Japan Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure South Korea Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure India Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Australia Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Indonesia Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Thailand Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Malaysia Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Philippines Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Vietnam Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Central & South America Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table Central & South America Human Insulin Drugs And Delivery Devices Consumption by Type (2014-2019) (K Units)
  • Figure Central & South America Human Insulin Drugs And Delivery Devices Consumption Market Share by Type in 2018
  • Table Central & South America Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Figure Central & South America Human Insulin Drugs And Delivery Devices Consumption Market Share by Application in 2018
  • Table Central & South America Human Insulin Drugs And Delivery Devices Consumption by Countries (2014-2019) (K Units)
  • Figure Central & South America Human Insulin Drugs And Delivery Devices Consumption Market Share by Countries
  • Figure Brazil Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption by Type (2014-2019) (K Units)
  • Figure Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption Market Share by Type in 2018
  • Table Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption by Application (2014-2019) (K Units)
  • Figure Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption Market Share by Application in 2018
  • Figure Turkey Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure GCC Countries Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure Egypt Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Figure South Africa Human Insulin Drugs And Delivery Devices Consumption Growth Rate (2014-2019) (K Units)
  • Table Novo Nordisk Company Details
  • Table Novo Nordisk Description and Business Overview
  • Table Novo Nordisk Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Novo Nordisk Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Novo Nordisk Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Novo Nordisk Recent Development
  • Table Sanofi Aventis Company Details
  • Table Sanofi Aventis Description and Business Overview
  • Table Sanofi Aventis Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Sanofi Aventis Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Sanofi Aventis Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Sanofi Aventis Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Description and Business Overview
  • Table Eli Lilly Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Eli Lilly Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Eli Lilly Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Eli Lilly Recent Development
  • Table Biocon Company Details
  • Table Biocon Description and Business Overview
  • Table Biocon Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Biocon Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Biocon Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Biocon Recent Development
  • Table Julphar Company Details
  • Table Julphar Description and Business Overview
  • Table Julphar Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Julphar Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Julphar Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Julphar Recent Development
  • Table Exir Company Details
  • Table Exir Description and Business Overview
  • Table Exir Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Exir Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Exir Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Exir Recent Development
  • Table Medtronic Company Details
  • Table Medtronic Description and Business Overview
  • Table Medtronic Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Medtronic Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Medtronic Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Medtronic Recent Development
  • Table Insulet Company Details
  • Table Insulet Description and Business Overview
  • Table Insulet Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Insulet Recent Development
  • Table Insulet Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Insulet Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Ypsomed Company Details
  • Table Ypsomed Description and Business Overview
  • Table Ypsomed Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Ypsomed Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Ypsomed Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Ypsomed Recent Development
  • Table Becton Dickinson Company Details
  • Table Becton Dickinson Description and Business Overview
  • Table Becton Dickinson Human Insulin Drugs And Delivery Devices Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
  • Table Becton Dickinson Human Insulin Drugs And Delivery Devices Production Growth Rate (2014-2019)
  • Table Becton Dickinson Human Insulin Drugs And Delivery Devices Production Market Share in Global Market
  • Table Becton Dickinson Recent Development
  • Table Global Human Insulin Drugs And Delivery Devices Capacity, Production Forecast 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Capacity Forecast 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Forecast 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Forecast 2019-2025 (Million US$)
  • Table Global Human Insulin Drugs And Delivery Devices Revenue Forecast 2019-2025 (Million US$)
  • Table Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share Forecast by Regions 2019-2025
  • Table Global Human Insulin Drugs And Delivery Devices Production Forecast by Regions 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Forecast by Regions 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share Forecast by Regions 2019-2025
  • Table United States Human Insulin Drugs And Delivery Devices Production and Value Forecast 2019-2025 (K Units) & (Million US$)
  • Figure United States Human Insulin Drugs And Delivery Devices Production Forecast 2019-2025 (K Units)
  • Figure United States Human Insulin Drugs And Delivery Devices Revenue Forecast 2019-2025 (Million US$)
  • Table Europe Human Insulin Drugs And Delivery Devices Production and Value Forecast 2019-2025 (K Units) & (Million US$)
  • Figure Europe Human Insulin Drugs And Delivery Devices Production Forecast 2019-2025 (K Units)
  • Figure Europe Human Insulin Drugs And Delivery Devices Revenue Forecast 2019-2025 (Million US$)
  • Table China Human Insulin Drugs And Delivery Devices Production and Value Forecast 2019-2025 (K Units) & (Million US$)
  • Figure China Human Insulin Drugs And Delivery Devices Production Forecast 2019-2025 (K Units)
  • Figure China Human Insulin Drugs And Delivery Devices Revenue Forecast 2019-2025 (Million US$)
  • Table Japan Human Insulin Drugs And Delivery Devices Production and Value Forecast 2019-2025 (K Units) & (Million US$)
  • Figure Japan Human Insulin Drugs And Delivery Devices Production Forecast 2019-2025 (K Units)
  • Figure Japan Human Insulin Drugs And Delivery Devices Revenue Forecast 2019-2025 (Million US$)
  • Table Global Human Insulin Drugs And Delivery Devices Production Forecast by Type 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Forecast by Type 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Market Share Forecast by Type 2019-2025
  • Table Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Type 2019-2025 (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Type 2019-2025 (Million US$)
  • Figure Global Human Insulin Drugs And Delivery Devices Production Value Market Share Forecast by Type 2019-2025
  • Table Global Human Insulin Drugs And Delivery Devices Consumption Forecast by Application 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Forecast by Application 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Market Share Forecast by Application 2019-2025
  • Table Global Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure Global Human Insulin Drugs And Delivery Devices Consumption Market Share Forecast by Regions 2019-2025
  • Table North America Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure United States Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Canada Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Mexico Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Table Europe Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure Germany Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure France Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure UK Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Italy Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Russia Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Table Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure China Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Japan Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure South Korea Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure India Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Australia Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Indonesia Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Thailand Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Malaysia Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Philippines Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Vietnam Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Table Central & South America Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure Brazil Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Table Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025 (K Units)
  • Figure Turkey Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure GCC Countries Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Egypt Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure South Africa Human Insulin Drugs And Delivery Devices Consumption Forecast 2019-2025 (K Units)
  • Figure Human Insulin Drugs And Delivery Devices Value Chain
  • Table Human Insulin Drugs And Delivery Devices Distributors List
  • Table Human Insulin Drugs And Delivery Devices Customers List
  • Table Porter's Five Forces Analysis
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources

Human insulin drugs and delivery devices are mainly used for injecting the insulin in the human body.

The Human Insulin Drugs And Delivery Devices market was valued at xx Million US$ in 2018 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Insulin Drugs And Delivery Devices.

This study focuses on the production side and consumption side of Human Insulin Drugs And Delivery Devices, presents the global Human Insulin Drugs And Delivery Devices market size by manufacturers, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

In terms of production side, this report researches the Human Insulin Drugs And Delivery Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.

In terms of consumption side, this report focuses on the consumption of Human Insulin Drugs And Delivery Devices by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Novo Nordisk
  • Sanofi Aventis
  • Eli Lilly
  • Biocon
  • Julphar
  • Exir
  • Medtronic
  • Insulet
  • Ypsomed
  • Becton Dickinson

Market Segment by Product Type

  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Basal or Long Acting Insulins
  • Bolus or Fast-Acting Insulins

Market Segment by Application

  • Hospital
  • Household

Key Regions split in this report:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Human Insulin Drugs And Delivery Devices status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Human Insulin Drugs And Delivery Devices manufacturers, capacity, production, revenue, market share, and recent development.
  • To split the breakdown data by regions, type, manufacturers and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Insulin Drugs And Delivery Devices are as follows:

  • History Year: 2014-2019
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

Table of Contents

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Major Manufacturers Covered in This Report
  • 1.3 Market Segment by Type
    • 1.3.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type
    • 1.3.2 Insulin Pumps
    • 1.3.3 Insulin Pens
    • 1.3.4 Insulin Syringes
    • 1.3.5 Basal or Long Acting Insulins
    • 1.3.6 Bolus or Fast-Acting Insulins
  • 1.4 Market Segment by Application
    • 1.4.1 Global Human Insulin Drugs And Delivery Devices Market Share by Application (2019-2025)
    • 1.4.2 Hospital
    • 1.4.3 Household
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Production and Capacity Analysis
    • 2.1.1 Global Human Insulin Drugs And Delivery Devices Production Value 2014-2025
    • 2.1.2 Global Human Insulin Drugs And Delivery Devices Production 2014-2025
    • 2.1.3 Global Human Insulin Drugs And Delivery Devices Capacity 2014-2025
    • 2.1.4 Global Human Insulin Drugs And Delivery Devices Marketing Pricing and Trends
  • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
    • 2.2.1 Global Human Insulin Drugs And Delivery Devices Market Size CAGR of Key Regions
    • 2.2.2 Global Human Insulin Drugs And Delivery Devices Market Share of Key Regions
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Market Share by Manufacturers

  • 3.1 Capacity and Production by Manufacturers
    • 3.1.1 Global Human Insulin Drugs And Delivery Devices Capacity by Manufacturers
    • 3.1.2 Global Human Insulin Drugs And Delivery Devices Production by Manufacturers
  • 3.2 Revenue by Manufacturers
    • 3.2.1 Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2014-2019)
    • 3.2.2 Human Insulin Drugs And Delivery Devices Revenue Share by Manufacturers (2014-2019)
    • 3.2.3 Global Human Insulin Drugs And Delivery Devices Market Concentration Ratio (CR5 and HHI)
  • 3.3 Human Insulin Drugs And Delivery Devices Price by Manufacturers
  • 3.4 Key Manufacturers Human Insulin Drugs And Delivery Devices Plants/Factories Distribution and Area Served
  • 3.5 Date of Key Manufacturers Enter into Human Insulin Drugs And Delivery Devices Market
  • 3.6 Key Manufacturers Human Insulin Drugs And Delivery Devices Product Offered
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Production and Production Value for Each Type
    • 4.1.1 Insulin Pumps Production and Production Value (2014-2019)
    • 4.1.2 Insulin Pens Production and Production Value (2014-2019)
    • 4.1.3 Insulin Syringes Production and Production Value (2014-2019)
    • 4.1.4 Basal or Long Acting Insulins Production and Production Value (2014-2019)
    • 4.1.5 Bolus or Fast-Acting Insulins Production and Production Value (2014-2019)
  • 4.2 Global Human Insulin Drugs And Delivery Devices Production Market Share by Type
  • 4.3 Global Human Insulin Drugs And Delivery Devices Production Value Market Share by Type
  • 4.4 Human Insulin Drugs And Delivery Devices Ex-factory Price by Type

5 Market Size by Application

  • 5.1 Overview
  • 5.2 Global Human Insulin Drugs And Delivery Devices Consumption by Application

6 Production by Regions

  • 6.1 Global Human Insulin Drugs And Delivery Devices Production (History Data) by Regions 2014-2019
  • 6.2 Global Human Insulin Drugs And Delivery Devices Production Value (History Data) by Regions
  • 6.3 United States
    • 6.3.1 United States Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019
    • 6.3.2 United States Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019
    • 6.3.3 Key Players in United States
    • 6.3.4 United States Human Insulin Drugs And Delivery Devices Import & Export
  • 6.4 Europe
    • 6.4.1 Europe Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019
    • 6.4.2 Europe Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019
    • 6.4.3 Key Players in Europe
    • 6.4.4 Europe Human Insulin Drugs And Delivery Devices Import & Export
  • 6.5 China
    • 6.5.1 China Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019
    • 6.5.2 China Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019
    • 6.5.3 Key Players in China
    • 6.5.4 China Human Insulin Drugs And Delivery Devices Import & Export
  • 6.6 Japan
    • 6.6.1 Japan Human Insulin Drugs And Delivery Devices Production Growth Rate 2014-2019
    • 6.6.2 Japan Human Insulin Drugs And Delivery Devices Production Value Growth Rate 2014-2019
    • 6.6.3 Key Players in Japan
    • 6.6.4 Japan Human Insulin Drugs And Delivery Devices Import & Export
  • 6.7 Other Regions
    • 6.7.1 South Korea
    • 6.7.2 India
    • 6.7.3 Southeast Asia

7 Human Insulin Drugs And Delivery Devices Consumption by Regions

  • 7.1 Global Human Insulin Drugs And Delivery Devices Consumption (History Data) by Regions
  • 7.2 North America
    • 7.2.1 North America Human Insulin Drugs And Delivery Devices Consumption by Type
    • 7.2.2 North America Human Insulin Drugs And Delivery Devices Consumption by Application
    • 7.2.3 North America Human Insulin Drugs And Delivery Devices Consumption by Countries
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3 Europe
    • 7.3.1 Europe Human Insulin Drugs And Delivery Devices Consumption by Type
    • 7.3.2 Europe Human Insulin Drugs And Delivery Devices Consumption by Application
    • 7.3.3 Europe Human Insulin Drugs And Delivery Devices Consumption by Countries
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 UK
    • 7.3.7 Italy
    • 7.3.8 Russia
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Type
    • 7.4.2 Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Application
    • 7.4.3 Asia Pacific Human Insulin Drugs And Delivery Devices Consumption by Regions
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 Indonesia
    • 7.4.10 Thailand
    • 7.4.11 Malaysia
    • 7.4.12 Philippines
    • 7.4.13 Vietnam
  • 7.5 Central & South America
    • 7.5.1 Central & South America Human Insulin Drugs And Delivery Devices Consumption by Type
    • 7.5.2 Central & South America Human Insulin Drugs And Delivery Devices Consumption by Application
    • 7.5.3 Central & South America Human Insulin Drugs And Delivery Devices Consumption by Countries
    • 7.5.4 Brazil
  • 7.6 Middle East and Africa
    • 7.6.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption by Type
    • 7.6.2 Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption by Application
    • 7.6.3 Central & South America Human Insulin Drugs And Delivery Devices Consumption by Countries
    • 7.6.4 Turkey
    • 7.6.5 GCC Countries
    • 7.6.6 Egypt
    • 7.6.7 South Africa

8 Company Profiles

  • 8.1 Novo Nordisk
    • 8.1.1 Novo Nordisk Company Details
    • 8.1.2 Company Description and Business Overview
    • 8.1.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.1.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.1.5 Novo Nordisk Recent Development
  • 8.2 Sanofi Aventis
    • 8.2.1 Sanofi Aventis Company Details
    • 8.2.2 Company Description and Business Overview
    • 8.2.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.2.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.2.5 Sanofi Aventis Recent Development
  • 8.3 Eli Lilly
    • 8.3.1 Eli Lilly Company Details
    • 8.3.2 Company Description and Business Overview
    • 8.3.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.3.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.3.5 Eli Lilly Recent Development
  • 8.4 Biocon
    • 8.4.1 Biocon Company Details
    • 8.4.2 Company Description and Business Overview
    • 8.4.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.4.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.4.5 Biocon Recent Development
  • 8.5 Julphar
    • 8.5.1 Julphar Company Details
    • 8.5.2 Company Description and Business Overview
    • 8.5.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.5.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.5.5 Julphar Recent Development
  • 8.6 Exir
    • 8.6.1 Exir Company Details
    • 8.6.2 Company Description and Business Overview
    • 8.6.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.6.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.6.5 Exir Recent Development
  • 8.7 Medtronic
    • 8.7.1 Medtronic Company Details
    • 8.7.2 Company Description and Business Overview
    • 8.7.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.7.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.7.5 Medtronic Recent Development
  • 8.8 Insulet
    • 8.8.1 Insulet Company Details
    • 8.8.2 Company Description and Business Overview
    • 8.8.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.8.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.8.5 Insulet Recent Development
  • 8.9 Ypsomed
    • 8.9.1 Ypsomed Company Details
    • 8.9.2 Company Description and Business Overview
    • 8.9.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.9.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.9.5 Ypsomed Recent Development
  • 8.10 Becton Dickinson
    • 8.10.1 Becton Dickinson Company Details
    • 8.10.2 Company Description and Business Overview
    • 8.10.3 Production and Revenue of Human Insulin Drugs And Delivery Devices
    • 8.10.4 Human Insulin Drugs And Delivery Devices Product Introduction
    • 8.10.5 Becton Dickinson Recent Development

9 Market Forecast: Production Side

  • 9.1 Production and Production Value Forecast
    • 9.1.1 Global Human Insulin Drugs And Delivery Devices Capacity, Production Forecast 2019-2025
    • 9.1.2 Global Human Insulin Drugs And Delivery Devices Production Value Forecast 2019-2025
  • 9.2 Human Insulin Drugs And Delivery Devices Production and Production Value Forecast by Regions
    • 9.2.1 Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Regions
    • 9.2.2 Global Human Insulin Drugs And Delivery Devices Production Forecast by Regions
  • 9.3 Human Insulin Drugs And Delivery Devices Key Producers Forecast
    • 9.3.1 United States
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 Other Regions
  • 9.4 Forecast by Type
    • 9.4.1 Global Human Insulin Drugs And Delivery Devices Production Forecast by Type
    • 9.4.2 Global Human Insulin Drugs And Delivery Devices Production Value Forecast by Type

10 Market Forecast: Consumption Side

  • 10.1 Consumption Forecast by Application
  • 10.2 Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions
  • 10.3 North America Market Consumption Forecast
    • 10.3.1 North America Human Insulin Drugs And Delivery Devices Consumption Forecast by Countries 2019-2025
    • 10.3.2 United States
    • 10.3.3 Canada
    • 10.3.4 Mexico
  • 10.4 Europe Market Consumption Forecast
    • 10.4.1 Europe Human Insulin Drugs And Delivery Devices Consumption Forecast by Countries 2019-2025
    • 10.4.2 France
    • 10.4.3 UK
    • 10.4.4 Italy
    • 10.4.5 Russia
  • 10.5 Asia Pacific Market Consumption Forecast
    • 10.5.1 Asia Pacific Human Insulin Drugs And Delivery Devices Consumption Forecast by Regions 2019-2025
    • 10.5.2 Japan
    • 10.5.3 South Korea
    • 10.5.4 India
    • 10.5.5 Australia
    • 10.5.6 Indonesia
    • 10.5.7 Thailand
    • 10.5.8 Malaysia
    • 10.5.9 Philippines
    • 10.5.10 Vietnam
  • 10.6 Central & South America Market Consumption Forecast
    • 10.6.1 Central & South America Human Insulin Drugs And Delivery Devices Consumption Forecast by Country 2019-2025
  • 10.7 Middle East and Africa Market Consumption Forecast
    • 10.7.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Consumption Forecast by Countries 2019-2025
    • 10.7.2 GCC Countries
    • 10.7.3 Egypt
    • 10.7.4 South Africa

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Human Insulin Drugs And Delivery Devices Sales Channels
    • 11.2.2 Human Insulin Drugs And Delivery Devices Distributors
  • 11.3 Human Insulin Drugs And Delivery Devices Customers

12 Opportunities & Challenges, Threat and Affecting Factors

  • 12.1 Market Opportunities
  • 12.2 Market Challenges
  • 12.3 Porter's Five Forces Analysis

13 Key Findings

14 Appendix

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
      • 14.1.1.1 Research Programs/Design
      • 14.1.1.2 Market Size Estimation
      • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
      • 14.1.2.1 Secondary Sources
      • 14.1.2.2 Primary Sources
  • 14.2 Author Details
  • 14.3 Disclaimer
Back to Top
전화 문의
F A Q